Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "erbitux"

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck
Pharma Letter

Merck to assume responsibility for promoting Erbitux in Japan

Merck has announced that it will take full responsibility for the promotion of Erbitux from Bristol-Myers in Japan, effective from May 1, 2015. "Expanding our oncology presence in Japan is of strategic importance to achieve our long term ambition to ... Individual.com, 1 month ago
[x]  

4 images for erbitux

Pharma Letter, 1 month ago
Pharma Letter, 1 month ago
Pharma Letter, 1 month ago
Pharma Letter, 1 month ago

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Revision: 24, Authorised

This is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago Information sent to healthcare professionals in January about the safety of medicines  MHRA1 month ago Scottish Medicines Consortium: cetuximab (Erbitux)  FirstWord Pharma2 months ago

Erbitux-Drug Insights,2014

Summary 'Erbitux - Drug Insights, 2014' provides Erbitux marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent ...
 Individual.com2 months ago

Research and Markets: Antibodies in Oncology Drug Pipeline Update 2015 - 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the ...
 Morningstar.com1 month ago Antibodies in Oncology Drug Pipeline Update 2015  Global Information Inc2 months ago Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  Individual.com2 months ago Research and Markets: Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  TMC Net2 months ago
[x]  

Merck KGaA to Gain Full Marketing Rights to Erbitux in Japan - Analyst Blog

Merck KGaA ( MKGAF ) announced that it will acquire full responsibility for the promotion of Erbitux from Bristol-Myers Squibb Company ( BMY ) in Japan. We remind investors that Erbitux was launched in Japan in Sep 2008 under partnership with ...
 Zacks.com1 month ago Full-year sales in Merck KGaA's Serono unit lifted by fertility franchise, emerging markets  FirstWord Pharma3 weeks ago
[x]  

Forum Post: Chinese Lingzhi mushrooms as a supplement to Erbitux

my dad has larynx tumour and is going to be treated with Erbitux/Cetuximab +Radio. My sister and me we are very anxious about side effects of this treatment and we are thinking of different ways how it might be possible to support his body and make ...
 Macmillan Cancer Support1 week ago Forum Post: RE: Chinese Lingzhi mushrooms as a supplement to Erbitux  Macmillan Cancer Support6 days ago

New and Generic Drug Approvals: Erbitux

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration2 weeks ago

Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog

Sales of another oncology drug, Erbitux, slightly improved during the quarter. Erbitux sales increased 1% to $181 million in the reported quarter. Opdivo, which gained accelerated approval in Dec 2014 for the melanoma indication based on tumor ...
 Nasdaq1 month ago

ELI LILLY : An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ACCESS ERBITUX" by Robert E. Lee , Jr., ...
 4 Traders2 months ago An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly  Insurance News Net2 months ago

SMC recommends Erbitux for use in the first line treatment of metastatic bowel cancer patients in Scotland

Erbitux (cetuximab), in combination with FOLFIRI or FOLFOX, has been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for the first line treatment of metastatic bowel cancer , a disease which affects over 4,000 new ...
 Medical News Today2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less